Search Results - "Comisar, Wendy"
-
1
Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: A combined computational and experimental approach
Published in Biomaterials (01-10-2007)“…Abstract The adhesion ligand arginine–glycine–aspartic acid (RGD) has been coupled to various materials to be used as tissue culture matrices or cell…”
Get full text
Journal Article -
2
A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer
Published in Clinical cancer research (15-11-2009)“…Purpose: This dedicated QTc phase I study, conducted in advanced-stage cancer patients, assessed the effect of a single supratherapeutic dose (800 mg) of…”
Get full text
Journal Article -
3
Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogels
Published in Biomaterials (01-04-2006)“…The adhesion ligand RGD has been coupled to various materials to be used as tissue culture matrices or cell transplantation vehicles, and recent studies…”
Get full text
Journal Article -
4
Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation
Published in Nano letters (01-08-2004)“…It was hypothesized that nanoscale adhesion ligand spacing regulates cell adhesion, proliferation, and differentiation, and that this control can be decoupled…”
Get full text
Journal Article -
5
A semimechanistic model of the time‐course of release of PTH into plasma following administration of the calcilytic JTT‐305/MK‐5442 in humans
Published in Journal of bone and mineral research (01-08-2013)“…ABSTRACT JTT‐305/MK‐5442 is a calcium‐sensing receptor (CaSR) allosteric antagonist being investigated for the treatment of osteoporosis. JTT‐305/MK‐5442 binds…”
Get full text
Journal Article -
6
Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants
Published in Journal of clinical pharmacology (01-02-2011)“…Caspofungin was the first in a new class of antifungal agents (echinocandins) indicated for the treatment of primary and refractory fungal infections. Higher…”
Get full text
Journal Article -
7
Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals
Published in Antiviral therapy (01-01-2010)“…Atazanavir plus raltegravir 300/400 mg twice daily is being explored as a ritonavir- and nucleoside-sparing treatment strategy. The pharmacokinetics and safety…”
Get more information
Journal Article -
8
Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis
Published in Clinical pharmacology in drug development (01-01-2014)“…Caspofungin is an echinocandin antifungal agent administered once daily as an intravenous infusion. Relationships between caspofungin exposure and clinical…”
Get full text
Journal Article -
9
Adhesion ligand nanopatterning influences differentiation of preosteoblast cells: a combined experimental and computational approach
Published in Developmental biology (01-07-2006)Get full text
Journal Article -
10
Controlling osteogenesis through nanoscale organization of adhesion ligand in alginate hydrogels
Published 01-01-2007“…The adhesion ligand RGD (arginine-glycine-aspartic acid) has been coupled to various materials to be used as tissue culture matrices or cell transplantation…”
Get full text
Dissertation